Intertek Melbourn employee Andrea Cusack presented Technological Advances Bridging the Gap for Patients, Clinicians, and Industry Using AI Moderated Interviews at the 5th Annual Inhaled & Nasal Biologics | DNA Forum on 24–25 September 2026 at Hinxton Hall, Cambridge, UK.
Public source
Publisher name
Public post
🎤 Speaker Spotlight: Andrea Cusack, CEO, Nebu~Flow As healthcare becomes increasingly patient-centred, there is growing recognition of the need to better capture patien…
Company
Intertek Melbourn
Pharmaceutical analysis & formulation contract services. Specialist expertise in inhalation & nasal drug development
- Industry
- Pharmaceutical Manufacturing
- Location
- Cambridge, GB
- Company size
- 51–200 employees
About Intertek Melbourn
A leading provider of pharmaceutical analysis and formulation support with 30+ years of experience in inhaled product development and Good Manufacturing Practice (GMP) compliant analytical testing and stability storage services. We have a reputation for providing outstanding and responsive customer service. Previously known as Melbourn Scientific Ltd, the laboratory, based near Cambridge UK, was acquired by Intertek in 2013. We opened a second facility in 2015 and another in 2019 leading to further expansion which has doubled our laboratory footprint. We have specialist skills and experience in analytical testing and formulation for inhaled and intranasal products as well as all other dosage forms for healthcare products. Clients include major pharmaceutical companies, drug delivery innovators, consultants and virtual companies. We have invested continually in the latest equipment and provides a range of services; pre-formulation and formulation, analytical support, method development and validation; stability studies and storage and accelerated feasibility studies. The laboratory is inspected and approved by the UK Medicines & Healthcare Products Regulatory Agency (MHRA) for GMP compliance. The Laboratory has also been inspected by the US Food and Drug Administration (FDA) against GMP as part of clients’ pre-approval inspections. Pharmaceutical Analytical Services Early Stage Pre-formulation support Formulation Development Orally Inhaled Product Development Inhalation Product Analysis And Testing Nasal Drug Product Development Analytical Method Development Method Validation Stability Storage and Testing Dissolution Testing Particle and Drop Characterization and Sizing Product Characterization Chemicals, Manufacturing and Controls (CMC) Support Clinical Trial GMP Manufacture QC Testing
See moreLatest activity
Latest activity from Intertek Melbourn
9 signals
Presence & Recognition
Intertek Melbourn Principle Scientists Stacey Crane, Martin Westcott and Sam Clarke are attending the International Conference on Inhalation Drug Delivery in Parma to discuss emerging research, development challenges, and opportunities for innovation.
Presence & Recognition
Intertek Melbourn attended the PharmSci2026 event hosted by the Academy of Pharmaceutical Sciences.
Presence & Recognition
Intertek Melbourn participated in Day 3 of the European Respiratory Society Congress 2026 in Barcelona.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
IQVIA Laboratories
IQVIA Laboratories featured Elisa Pasqua in a poster titled #358 at the EFMC next week.
Presence & Recognition
AstraZeneca
AstraZeneca employee Olga Obrezanova will speak at the Festival of Biologics 2026 in Basel this October on Integrating AI/ML into Biologics Discovery.
Presence & Recognition
Transformative Pharmaceutical Solutions
Transformative Pharmaceutical Solutions employee Xoli Belgrave, VP of Account Development, is scheduled to speak as a Site Support Soapbox speaker at Partnerships with Sites 2026 on September 14, 2026, at the Sheraton Boston event.
Presence & Recognition
Kindeva Drug Delivery
Kindeva Drug Delivery employee Nick Smalley will be attending the Exploring the Future of Inhalation Drug Delivery round table event in Parma on Wednesday, September 9 at 12:20.
Presence & Recognition
SK pharmteco